Puerto Rico Just Became the Latest U.S. Territory to Explore a Psychedelic Research Pilot
Governor Jenniffer González-Colón signed Executive Order 2026-037 on August 4, directing Puerto Rico's Department of Health to evaluate a pilot clinical research program covering ibogaine, psilocybin, and MDMA, with veterans first in line if it moves forward. The order creates a Scientific and Regulatory Advisory Committee — psychiatrists, pharmacologists, ethicists — to weigh the evidence, assess what infrastructure the island would need, and pursue funding and partnerships with the NIH, FDA, VA, and DEA. It's explicitly a feasibility study, not a green light: the order states outright that it does not authorize any clinical use of these compounds yet. That puts Puerto Rico alongside a growing list of U.S. jurisdictions — Texas, Colorado, Connecticut, New Jersey — exploring psychedelic research pilots ahead of any federal approval, each with its own scope and guardrails.
Read at Marijuana Moment